Male breast cancer

International Journal of Clinical Practice

Volumn 52, Issue 8, 1998, Pages 571-576

  Jepson, A S ^a   Fentiman, I S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER STAGING; EARLY DIAGNOSIS; HEALTH EDUCATION; HUMAN; LYMPH NODE DISSECTION; MALE; MALE BREAST; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR VOLUME;

BREAST NEOPLASMS, MALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; TOPOGRAPHY, MEDICAL;

EID: 0031771823     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. American Cancer Society. Cancer facts and figures, 1994. New York: American Cancer Society 1994: 6.
2. La Vecchia C, Levi F, Lucchini F. Descriptive epidemiology of male breast cancer in Europe. Int J Cancer 1992; 51: 62-66.
3. Sandeler B, Carman C, Perry RR. Cancer of the male breast. Am Surg 1994; 60: 816-820.
4. Jonasson JG, Agnarsson BA, Thorlacius S et al. Male breast cancer in Iceland. Int J Cancer 1996; 65: 446-449.
5. Salvadori B, Saccozzi R, Manzari A et al. Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 1994; 30A: 930-935.
6. Fentiman IS. Male breast cancer. In: Detection and treatment of early breast cancer. London: Martin Dunitz 1990; 207-217.
7. Ewertz M, Holmberg L, Karjalainen S et al. Incidence of male breast cancer in Scandinavia. Int J Cancer 1989; 43: 27-31.
8. Muir C, Waterhouse J, Mack T, Powell JR, eds. Cancer incidence in five continents. Vol V. Lyon: IARC Science Publishers 1987: 882-883.
9. El-Gazayerli MM, Abdel-Aziz AS. On bilharziasis and male breast cancer in Egypt: a preliminary report and review of the literature. Br J Cancer 1963; 17: 566-571.
10. Sasco J, Lowenfels AB, Pasker-de-Jong P. Review of article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993; 53: 538-549.
11. Bhagwandeen SS. Carcinoma of the male breast in Zambia. East Afr Med J 1972; 49: 89-93.
12. Amir H, Makwaya CK, Moshiro C, Kwesigabo G. Carcinoma of the male breast: a sexually transmitted disease? East Afr Med J 1996; 73(3): 187-190.
13. Simon MS, McKnight E, Schwartz A et al. Racial differences in cancer of the male breast: 15-year experience in the Detroit metropolitan area. Breast Cancer Res Treat 1992; 21: 55-62.
14. Mabuchi K, Bross DS, Kessler II. Risk factors for male breast cancer. J Natl Cancer Inst 1985; 74: 371-375.
15. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991; 48: 232-242.
16. D'Avanzo B, La Vecchia C. Risk factors for male breast cancer. Br J Cancer 1995; 71: 1359-1362.
17. Anderson DE, Badzioch MD. Breast cancer risks in relatives of male breast cancer patients. J Natl Cancer Inst 1992; 84: 1114-1117.
18. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
19. Wooster R, Neuhausen SI, Mangion J et al. Localisation of a breast cancer susceptibility gene (BRCA2) to chromosome 13q12-13. Science 1994; 265: 2088-2090.
20. Easton DF, Bishop DT, Ford D, Crockford GP. The breast cancer linkage consortium. Genetic analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52: 678-701.
21. Struewing JP, Brody LC, Erdos MR et al. Detection of eight mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 1995; 57: 1-7.
22. Anelli A, Anelli TF, Youngsin B et al. Mutations of the p53 gene in male breast cancer. Cancer 1995; 75: 2233-2238.
23. Joshi MG, Lee AKC, Loda M et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 1996; 77(3): 490-498.
24. Lenfant-Pejovic M-H, Mlika-Cabanne N, Bouchardy C et al. Risk factors for male breast cancer: a Franco-Swiss case-control study. Int J Cancer 1990; 45: 661-664.
25. McLaughlin JK, Malker HSR, Blot WJ et al. Occupational risks for male breast cancer in Sweden. Br J Ind Med 1988; 45: 275-276.
26. Loomis DP. Cancer of the breast among men in electrical occupations. Lancet 1992; 339: 1482-1483.
27. Matsanoski GM, Breysse PN, Elliott EA. Electromagnetic fields and male breast cancer. Lancet 1991; 337: 737.
28. Casagrande JT, Hanisch R, Pike MC et al. A case-control study of male breast cancer. Cancer Res 1988; 48: 1326-1330.
29. Rosenblatt KA, Thomas DB, Jimenez IM et al. Exposure to ionizing radiation and breast cancer in men. Am J Epidemiol 1990; 132: 776.
30. Jackson AW, Muldal S, Ockey CH et al. Carcinoma of the male breast in association with the Klinefelter's syndrome. BMJ 1965; 1: 223-225.
31. Evans DB, Crichlow RW. Carcinoma of the male breast and Klinefelter's syndrome. Cancer J Clin 1987; 37: 246-251.
32. McClure JA, Higgins CC. Bilateral carcinoma of the male breast after estrogen therapy. JAMA 1951; 146: 7-9.
33. Symmers WC. Carcinoma of the breast in transsexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. BMJ 1968; 2: 83-85.
34. Tsubara A, Hatano T, Murata A et al. Breast cancer in patients receiving neuroleptic therapy. Acta Pathol Jpn 1992; 42: 494-499.
35. Haga S, Watanabe O, Shimizu T et al. Breast cancer in a male with prolactinoma. Surg Today 1993; 23: 251-253.
36. Olsson H, Ranstam J. Head trauma and exposure to prolactin-elevating drugs as risk factors for male breast cancer. J Natl Cancer Inst 1988; 80: 679-683.
37. Scheike O, Visfeldt J. Male breast cancer. 4: Gynaecomastia in patients with breast cancer. Acta Pathol Microbiol Scand 1973; 81: 359-365.
38. Donegan WL. Redlich PN. Breast cancer in men. Surg Clin North Am 1996; 76(2): 343-363.
39. Van Geel AN, van Slooten EA, Mavrunac M et al. A retrospective study of male breast cancer in Holland. Br J Surg 1985; 72: 724-727.
40. Braunstein GD. Gynaecomastia. New Engl J Med 1993; 328: 490-495.
41. O'Hanlon DM, Kent P, Kerin MJ et al. Unilateral breast masses in men over 40: a diagnostic dilemma. Am J Surg 1995; 170: 24-26.
42. Cutuli B, Lacroze M, Dilhuydt JM et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 1995; 31A(12): 1960-1964.
43. Crichlow RW, Galt SW. Male breast cancer. Surg Clins North Am 1990; 70: 1165-1177.
44. Ribeiro G. Male breast carcinoma: a review of 301 cases from the Christie Hospital and Holt Radium Institute. Br J Cancer 1985; 51: 115-119.
45. Hodson GR, Urdanata LF, Al-Jurf AS et al. Male breast cancer. Am Surg 1985; 51: 47-49.
46. Scheike O. Male breast cancer. 5. Clinical manifestations in 257 cases in Denmark. Br J Cancer 1973; 28: 552-561.
47. Wainwright DM. Carcinoma of the male breast. Arch Surg 1927; 14: 836-860.
48. Desai DC, Brennan EJ Jr. Paget's disease of the male breast. Am Surg 1996; 62(12): 1068-1072.
49. Satiani B, Powell BW, Matthews WH. Paget's disease of the male breast. Arch Surg 1977; 112: 587-592.
50. Stewart RAL, Howlett DC, Heam FJ. Pictorial review: the imaging of male breast disease. Clin Radiol 1997; 52: 739-744.
51. Ambrogetti D, Ciatto S, Catarzi S et al. The combined diagnosis of male breast cancer lesions: a review of series of 748 consecutive cases. Radiol Medica 1996; 91(4): 356-359.
52. Borgen PI, Wong GY, Vlamis V et al. Current management of breast cancer: a review of 104 cases. Ann Surg 1992; 215: 451-457.
53. Donegan WL, Redlich PN. Breast cancer in men. Surg Clin North Am 1996; 76(2): 343-363.
54. Schuchardt U, Seegenschmiedt MH, Kirschner MJ et al. Adjuvant radiotherapy for breast carcinoma in men: a 20-year clinical experience. Am J Clin Oncol 1996; 19(4): 330-336.
55. Farrow JH, Adair FE. Effect of orchidectomy on skeletal metastases from cancer of male breast. Science 1942; 95: 654.
56. Kennedy BJ, Kiang DT. Hypophysectomy in the treatment of advanced cancer of the male breast. Cancer 1972; 29: 1606-1612.
57. Neifeld JP, Meyskens FL, Tormey DC et al. The role of orchidectomy in the management of advanced breast cancer. Cancer 1976; 37: 992-995.
58. Bezwoda WR, Hesdorffer C, Dansey R et al. Breast cancer in men: clinical features, hormone receptor status, and response to therapy. Cancer 1987; 60: 1337-1340.
59. Ribeiro GG, Swindell R, Harris M et al. A review of the management of the male breast cancer based on analysis of 420 treated cases. Breast 1996; 5: 141-146.
60. Patterson JS, Battersby LA, Bach BK. Use of tamoxifen in advanced male breast cancer. Cancer Treat Rep 1980; 64: 801-804.
61. Ribeiro G, Swindell R. Adjuvant tamoxifen for male breast cancer. Br J Cancer 1992; 65: 252-254.
62. Anelli FFM, Anelli A, Tran KN et al. Tamoxifen administration is associated with a high rate of treatment limiting symptoms in male breast cancer patients. Cancer 1986; 54: 657-660.
63. Patel HZ, Buzdar AV, Hortabagy GN. Role of adjuvant chemotherapy in male breast cancer. Cancer 1989; 64: 1583-1585.
64. Bagley CS, Wesley MN, Young RC et al. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 1987; 10: 55-60.
65. Guinee VF, Olsson H, Moller T et al. The prognosis of breast cancer in males. Cancer 1993; 71(1): 154-161.
66. Borgen PI, Senie RT, McKinnon WM, Rosen PP. Carcinoma of the male breast: analysis of prognosis compared with matched female patients. Ann Surg Oncol 1997; 4(5): 385-358.
67. Willsher PC, Leach IH, Ellis IO et al. A comparison outcome of male breast cancer with female breast cancer. Am J Surg 1997; 173: 185-188.